These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2629710)

  • 1. Treating chancroid: summary of studies in southern Africa.
    Ballard RC; Duncan MO; Fehler HG; Dangor Y; Exposto FL; Latif AS
    Genitourin Med; 1989 Jan; 65(1):54-7. PubMed ID: 2629710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chancroid, 1989.
    Schmid GP
    Rev Infect Dis; 1990; 12 Suppl 6():S580-9. PubMed ID: 2201074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating chancroid with enoxacin.
    Naamara W; Kunimoto DY; D'Costa LJ; Ndinya-Achola JO; Nsanze H; Ronald AR; Plummer FA
    Genitourin Med; 1988 Jun; 64(3):189-92. PubMed ID: 3044978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of chancroid.
    Schmid GP
    JAMA; 1986 Apr; 255(13):1757-62. PubMed ID: 3512872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
    Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of therapeutic response of patients with clinical chancroid to ciprofloxacin, erythromycin, and cotrimoxazole.
    D'Souza P; Pandhi RK; Khanna N; Rattan A; Misra RS
    Sex Transm Dis; 1998 Jul; 25(6):293-5. PubMed ID: 9662762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid.
    Fransen L; Nsanze H; Jo-Ndinya-Achola ; D'Costa L; Ronald AR; Piot P
    Sex Transm Dis; 1987; 14(2):98-101. PubMed ID: 2956702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya.
    Malonza IM; Tyndall MW; Ndinya-Achola JO; Maclean I; Omar S; MacDonald KS; Perriens J; Orle K; Plummer FA; Ronald AR; Moses S
    J Infect Dis; 1999 Dec; 180(6):1886-93. PubMed ID: 10558945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim.
    Plummer FA; Nsanze H; D'Costa LJ; Ndugga Maggwa AB; Girouard Y; Karasira P; Albritton WL; Ronald AR
    Rev Infect Dis; 1983; 5 Suppl 3():S565-72. PubMed ID: 6635447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
    Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for treatment of chancroid, 1993.
    Schulte JM; Schmid GP
    Clin Infect Dis; 1995 Apr; 20 Suppl 1():S39-46. PubMed ID: 7795108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.
    Naamara W; Plummer FA; Greenblatt RM; D'Costa LJ; Ndinya-Achola JO; Ronald AR
    Am J Med; 1987 Apr; 82(4A):317-20. PubMed ID: 3555055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen.
    Dylewski J; Nsanze H; D'Costa L; Slaney L; Ronald A
    J Antimicrob Chemother; 1985 Jul; 16(1):103-9. PubMed ID: 3876325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
    Abeck D; Johnson AP; Dangor Y; Ballard RC
    J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of spectinomycin and erythromycin in the treatment of chancroid.
    Ballard RC; da L'Exposto F; Dangor Y; Fehler HG; Miller SD; Koornhof HJ
    J Antimicrob Chemother; 1990 Sep; 26(3):429-34. PubMed ID: 2146242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of rosoxacin for the treatment of chancroid.
    Haase DA; Ndinya-Achola JO; Nash RA; D'Costa LJ; Hazlett D; Lubwama S; Nsanze H; Ronald AR
    Antimicrob Agents Chemother; 1986 Jul; 30(1):39-41. PubMed ID: 3489439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chancroid.
    Abeck D; Ballard RC
    Curr Probl Dermatol; 1996; 24():90-6. PubMed ID: 8743258
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
    Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
    J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose erythromycin regimen for the treatment of chancroid.
    Kimani J; Bwayo JJ; Anzala AO; MacLean I; Mwatha A; Choudri SH; Plummer FA; Ronald AR
    East Afr Med J; 1995 Oct; 72(10):645-8. PubMed ID: 8904044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.